W
2.99
-0.18 (-5.68%)
| Penutupan Terdahulu | 3.17 |
| Jumlah Dagangan | 68,192 |
| Harga / Buku (P/B) | 0.960 |
| Julat 52 Minggu |
| Margin Keuntungan | 99.42% |
| Margin Operasi (TTM) | -212.99% |
| EPS Cair (TTM) | 0.150 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 33.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1.59% |
| Nisbah Semasa (MRQ) | 18.95 |
| Aliran Tunai Operasi (OCF TTM) | -51.76 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -24.65 M |
| Pulangan Atas Aset (ROA TTM) | -21.92% |
| Pulangan Atas Ekuiti (ROE TTM) | 17.69% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Whitehawk Therapeutics, Inc. | Bercampur | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -0.2 |
| Purata Bergerak Teknikal | -1.5 |
| Osilator Teknikal | -2.5 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | -5.0 |
| Persekitaran Makro | -1.3 |
| AI Insight | NA |
| AI Technical | NA |
| Purata | -1.45 |
|
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 12.44% |
| % Dimiliki oleh Institusi | 67.64% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Yu Fan | 30 Jun 2026 | 4,861,314 |
| Acuta Capital Partners, Llc | 30 Jun 2026 | 4,685,912 |
| Qvt Financial Lp | 30 Jun 2026 | 4,615,709 |
| Montanova Capital, Llc | 30 Jun 2026 | 4,300,000 |
| Orbimed Advisors Llc | 30 Jun 2026 | 3,934,296 |
| Avoro Capital Advisors Llc | 30 Jun 2026 | 2,849,402 |
| Siren, L.L.C. | 30 Jun 2026 | 2,337,102 |
| Kvp Capital Advisors, Lp | 30 Jun 2026 | 2,165,997 |
| Acorn Capital Advisors, Llc | 30 Jun 2026 | 1,139,363 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |